Research
Macro partitioning
Circulating levels of soluble CD36 (sCD36) are abnormally elevated in NAFLD patients and positively correlate with the histological grade of hepatic steatosis, suggesting its utility as a biomarker.
Soluble CD36 levels in the blood may serve as a biomarker to assess the severity of fatty liver disease. This is a diagnostic tool rather than a treatment target for patients at this stage.
GoodSupportsHIGH confidence
Interestingly, circulating levels of a soluble form of CD36 (sCD36) are abnormally elevated in NAFLD patients and positively correlate with the histological grade of hepatic steatosis.
Why this rating
Based on clinical studies cited in the review.
Source
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Patricia Rada et al. · Cell Death and Disease · 2020
narrative_reviewCited 496×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →